Association of Obstructive Sleep Apnea With Urinary Albumin Excretion in Essential Hypertension: A Cross-sectional Study

American Journal of Kidney Diseases

Volumn 52, Issue 2, 2008, Pages 285-293

  Tsioufis, Costas ^a   Thomopoulos, Costas ^a   Dimitriadis, Kyriakos ^a   Amfilochiou, Anastasia ^b   Tsiachris, Dimitris ^a   Selima, Maria ^a   Petras, Dimitris ^c   Kallikazaros, Ioannis ^c   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b SISMANOGLIO HOSPITAL   (Greece)

^c HIPPOKRATION HOSPITAL   (Greece)

Author keywords

albuminuria; hypertension; Obstructive sleep apnea; risk factors; urinary albumin excretion

Indexed keywords

ALBUMIN;

ADULT; ALBUMINURIA; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BODY MASS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OUTPATIENT DEPARTMENT; POLYSOMNOGRAPHY; PULSE PRESSURE; RISK ASSESSMENT; SLEEP APNEA SYNDROME; SMOKING; UPPER RESPIRATORY TRACT OBSTRUCTION; URINALYSIS;

ADULT; ALBUMINURIA; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; UNITED STATES;

EID: 47149094110     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.05.001     Document Type: Article

References (43)

1. Nieto F.J., Young T.B., Lind B.K., et al., Sleep Heart Health Study. Association of sleep disordered breathing, sleep apnea and hypertension in a large community based study. JAMA 283 (2000) 1829-1836
2. Baguet J.P., Pepin J.L., Hammer L., Levy P., and Mallion J.M. Cardiovascular consequences of obstructive sleep apnea syndrome. Rev Med Int 24 (2003) 530-537
3. Alchanatis M., Tourkohoriti G., Kosmas E.N., et al. Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J 20 (2002) 1239-1245
4. Schulz R., Seeger W., Fegbeutel C., et al. Changes in extracranial arteries in obstructive sleep apnoea. Eur Respir J 25 (2005) 65-74
5. Silvestrini M., Rizzato B., Placidi F., Barufaldi R., Bianconi A., and Diomedi M. Carotid artery wall thickness in patients with obstructive sleep apnea syndrome. Stroke 33 (2002) 1782-1785
6. Drager L.F., Bortolotto L.A., Lorenzi M.C., Figueiredo A.C., Krieger E.M., and Lorenzi-Filho G. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172 (2005) 613-618
7. Tsioufis C., Thomopoulos K., Dimitriadis K., et al. The incremental effect of obstructive sleep apnoea syndrome on arterial stiffness in newly diagnosed essential hypertensive subjects. J Hypertens 25 (2007) 141-146
8. Ip M.S., Lam B., Ng M.M., Lam W.K., Tsang K.W., and Lam K.S. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165 (2002) 670-676
9. Wilcox I., McNamara S.G., Collins F.L., Grunstein R.R., and Sullivan C.E. "Syndrome Z": The interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 53 (1998) S25-S28 (suppl 3)
10. Pedrinelli R., Dell'Omo G., Di Bello V., Pontremoli R., and Mariani M. Microalbuminuria an integrated marker of cardiovascular risk in essential hypertension. J Hum Hypertens 16 (2002) 79-88
11. Pontremoli R., Sofia A., Ravera M., et al. Prevalence and clinical surrogates of microalbuminuria in essential hypertension. The MAGIC Study. Hypertension 30 (1997) 1135-1143
12. Gerstein H., Mann J., Yi Q., et al., Hope Study Investigators. Albuminuria and risk of cardiovascular events and heart failure in diabetic and non diabetic individuals. JAMA 286 (2001) 421-426
13. Verdecchia P., Schillacci G., Borgioni C., Ciucci A., Pede S., and Porcelati C. Ambulatory pulse pressure: A potent predictor of total cardiovascular risk in hypertension. Hypertension 32 (1998) 983-988
14. Chobanian A.V., Bakris G.L., Black H.R., et al., National Heart, Lung and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordination Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289 (2003) 2560-2572
15. Tsara V., Serasli E., Amfilochiou A., Constantinidis T., and Christaki P. Greek version of the Epworth Sleepiness Scale. Sleep Breathing 8 (2004) 91-95
16. American Academy of Sleep Medicine Task Force. The Report of the American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22 (1999) 667-689
17. American Academy of Sleep Medicine (AASM). International Classification of Sleep Disorders (2005), AASM, Westchester, IL
18. Tsioufis C., Stefanadis C., Antoniadis D., et al. Absence of any significant effects of circadian blood pressure variations on carotid artery elastic properties in essential hypertensive subjects. J Hum Hypertens 14 (2000) 813-818
19. Garcia-Rio F., Racionero M.A., Pino J.M., et al. Sleep apnea and hypertension. Chest 117 (2000) 1417-1425
20. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of left ventricular dimensions by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on quantization of two-dimensional echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
21. Tsioufis C., Dimitriadis K., Chatzis D., et al. Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am J Cardiol 96 (2005) 946-951
22. Berry J. Microalbuminuria testing in diabetes: Is a dipstick as effective as laboratory tests?. Br J Community Nurs 8 6 (2003) 267-273
23. Schwab S.J., Christensen R.L., Dougherty K., and Klahr S. Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples. Arch Intern Med 147 (1987) 943-944
24. Parsons M.P., Newman D.J., Newall R.G., and Price C.P. Validation of a point of care assay for the albumin:creatinine ratio. Clin Chem 45 (1999) 414-417
25. Clase C.M., Kiberd B.A., and Garg A.X. Relationship between glomerular filtration rate and the prevalence of metabolic abnormalities: Results from the Third National Health and Nutrition Examination Survey (NHANES III). Nephron Clin Pract 105 (2007) 178-184
26. Gimbone M.A., Topper Jr. J.N., Nagel T., Anderson K.R., and Garcia-Cardena G. Endothelial dysfunction, haemodynamic forces, and atherogenesis. Ann Acad Sci 902 (2000) 230-240
27. Jensen S., Feldt-Rasmussen B., Strandgaard S., Schroll M., and Borch-Jonhsen K. Arterial hypertension microalbuminuria and risk from ischemic heart disease. Hypertension 35 (2000) 898-903
28. Tsioufis C., Dimitriadis K., Stefanadis C., and Kallikazaros I. The emerging role of subclinical inflammation in hypertension-associated early renal dysfunction: Focus on microalbuminuria. Hellenic J Cardiol 47 (2006) 361-365
29. Faulx M.D., Storfer-Isser A., Kirchner H.L., et al. Obstructive sleep apnea is associated with increased urinary albumin excretion. Sleep 30 (2007) 923-929
30. Gruber A., Horwood F., Sithole J., Ali N.J., and Idris I. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 5 (2006) 22
31. Buchner N.J., Henning B.F., Hagele K.F., Quack I.A., and Rump L.C. Renal function in hypertensive patients with obstructive sleep apnea. Dtsch Med Wochenschr 129 (2004) 305-309
32. Chaundhary B.A., Sklar A.H., Chaundhary T.K., Kolbek R.C., and Speir W.A. Sleep apnea, proteinuria, and nephrotic syndrome. Sleep 11 (1988) 69-74
33. Krishna J., Shah Z.A., Merchant M., Klein J.B., and Gozal D. Urinary protein expression patterns in children with sleep disordered breathing: Preliminary findings. Sleep Med 7 (2006) 221-227
34. Shahar E., Whitney C.W., Redline S., et al. Sleep disordered breathing and cardiovascular disease. Cross sectional results from the Sleep Heart Health Study. Am J Crit Care Med 163 (2001) 19-25
35. Shamsuzzaman A.S., Winnicki M., Lafranchi P., et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105 (2002) 2462-2464
36. Ip M.S., Tse H.F., Lam B., Tsang K.W., and Lam W.K. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 163 (2004) 348-353
37. Oflaz H., Cuhadaroglu C., Pamukcu B., et al. Endothelial dysfunction in patients with obstructive sleep apnea syndrome but without hypertension. Respiration 73 (2006) 751-756
38. Tsioufis C., Dimitriadis K., Taxiarchou E., et al. Diverse associations of microalbuminuria with C reactive protein, interleukin 18, and soluble CD40 ligand in male essential hypertensive subjects. Am J Hypertens 19 (2006) 462-466
39. Tsioufis C., Dimitriadis K., Antoniadis D., et al. Inter-relationships of microalbuminuria with the other surrogates of the atherosclerotic cardiovascular disease in hypertensive subjects. Am J Hypertens 17 (2004) 470-476
40. Yokoe T., Minoguchi K., Matsuo H., et al. Elevated levels of C reactive protein and interleukin 6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107 (2003) 1129-1134
41. Hermans M.M., Henry R., Dekker J.M., et al. Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: The Hoorn Study. J Am Soc Nephrol 18 (2007) 1942-1952
42. Kramer H., Jacobs D.R., Bild D., et al. Urinary albumin excretion and cardiovascular disease. The Multi-Ethnic Study of Atherosclerosis. Hypertension 46 (2005) 38-43
43. Ohike Y., Kozaki K., Eto M., et al. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure: Possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J 69 (2005) 221-226